The skeletal muscle relaxant, vecuronium, acts at cholinergic receptors where it exhibits:
Correct Answer: Affinity but no efficacy
Description: Vecuronium is a curare-like drug classified as a nondepolarizing skeletal muscle relaxant. It exhibits pharmacologic antagonism by competing with acetylcholine for available N2-nicotinic receptors on the motor end plate. In this reversible mechanism, vecuronium exhibits affinity, or the ability to bind with a paicular receptor. Vecuronium does not elicit a response in the muscle cell it lacks efficacy, or effectiveness, the ability to produce an effect relative to a given number of drug-receptor complexes. Vecuronium prevents depolarization, thereby preventing the muscle cell from contracting. It has no effect on the regulation of receptor numbers at synapses. Ref: Hibbs R.E., Zambon A.C. (2011). Chapter 11. Agents Acting at the Neuromuscular Junction and Autonomic Ganglia. In L.L. Brunton, B.A. Chabner, B.C. Knollmann (Eds), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now